All news

Merck CEO sees faster production for cancer vaccine

CNBC · RSS · · AI-summarised by FinFlash

Merck's CEO told CNBC he expects the company's breakthrough cancer vaccine will become faster to make. His comments followed Merck's official opening of a new 120,000-square-foot research facility in the Greater Philadelphia area. The company is expanding its research footprint as it develops the vaccine.

Read original source

MRK company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.